The effect of Warfarin and factor VII on tissue procoagulant activity and pulmonary seeding.
Peri-tumour fibrin is a consistent feature of tumour stroma and is deposited shortly after tumour cell inoculation. Since there are several ways in which fibrin may be beneficial to tumour growth, it is possible that the ability of normal or malignant tissue to generate fibrin may influence metastasis. Many normal tissues and tumour cells possess a procoagulant activity that is due to a complex of tissue factor and factor VII. We have measured this tissue procoagulant activity in normal rats, rats stabilised on Warfarin and similarly anticoagulated animals injected with factor VII. The effect of Warfarin and factor VII administration on pulmonary seeding following injection of MC28 fibrosarcoma cells was also assessed. Procoagulant activity in adrenal, lung and colon was significantly reduced by Warfarin (P less than 0.001). Administration of factor VII significantly increased lung and adrenal tissue procoagulant activity in anticoagulated rats (P less than 0.02). Warfarinised rats had significantly slower primary tumour growth (P less than 0.001) and fewer lung deposits than control animals (P less than 0.001). Injection of factor VII restored pulmonary seeding to control levels (P less than 0.001). Warfarin did not affect the ability of the cells to adhere in vitro and did not reduce the number of tumour cells physically trapped in the lungs after intravenous injection. It is concluded that the procoagulant activity of normal tissues may influence their ability to support tumour growth and that the antimetastatic effect of Warfarin may be at least partly due to a reduction in the availability of the factor VII required for this activity.
Francis
J L
JL
University Department of Haematology, Southampton General Hospital, UK.
Carty
N
N
Amirkhosravi
M
M
Loizidou
M
M
Cooper
A
A
Taylor
I
I
D000311:Adrenal Glands / Q000378:metabolism; D000818:Animals; D002448:Cell Adhesion / Q000187:drug effects; D003106:Colon / Q000378:metabolism; D005167:Factor VII / Q000187:drug effects* / Q000494:pharmacology*; D005170:Factor X; D005354:Fibrosarcoma / Q000473:pathology* / Q000556:secondary*; D008099:Liver / Q000378:metabolism; D008168:Lung / Q000378:metabolism; D008175:Lung Neoplasms / Q000473:pathology* / Q000556:secondary*; D009366:Neoplasm Seeding; D009374:Neoplasms, Experimental; D051381:Rats; D013925:Thromboplastin / Q000187:drug effects*; D014859:Warfarin / Q000494:pharmacology*
D014859:Warfarin; D005167:Factor VII; D005170:Factor X; D013925:Thromboplastin